Tuesday, December 1, 2009
Poster Session: Reflection
So maybe, we could incorporate the following into our design project poster:
1. Step-by-step process laid out, including an introduction and final applications.
2. Diagrams, charts, pictures etc - that really would help.
3. Inserting marketing schemes; in the poster session, it was obvious that marketing the research would be beneficial to the students and researchers there because it could help them get more funding, market their product, etc.
4. Use simple, but professional terms and integrate them with pictures.
5. Make it look neat.
Overall, I really enjoyed the poster session today. It opened my eyes to what an outstanding poster was and what posters got lost in the shuffle.
Sunday, November 22, 2009
Thursday, November 19, 2009
Rough Logo
Company Name: CHARJJ
Potential Company Logo:
User Specs
CAPACITY | 200 doses |
SIZE | 5” x 4” x 2” |
Screen | 3.5” by 2.5” |
WEIGHT | 18 ounces (excluding batteries and medication bag) |
COST | $1000 – 1500 |
INTENDED USERS | Adults (specifically geared toward disabled adults and seniors) |
FEATURES | |
Front Panel | Red error button, Green in – use button, Yellow refill button Touch screen with manual buttons for backup: Start/stop button, Select and up/down buttons, Quick navigation buttons |
Side Panel | Emergency stop button, AC jack, Wi-Fi, Head cover dispenser |
FUNCTIONS | -Administer the drug -Clinician-only modification of dose quantity by increments of 0.1mL, 0.1μg, or 0.1mg -Keeps a record of patient’s dosage history (can be viewed in chart or line graph form) - Sends dosage history data to hospital after every use, through Wi-Fi àImmediately notifies hospital if patient attempts to modify dosage -Always displays drug name, current dose quantity, and remaining quantity at the top -Alerts patient when 50, 25, 20, 15, 10, 5, 4, 3, 2, and 1 doses have been used |
“Standby” mode | Center: shows countdown until patient can next take medication Right: indicates how many doses remain (represented with a gas meter) |
OPERATING CONDITIONS | Keep dry at room temperature; best to administer medication when PCA is elevated above patient’s head |
Approximately 120 hours at 10mL/hr (using 4 alkaline batteries) | |
USEFUL LIFE | Lifetime guarantee if PCA is used properly and taken care of (kept dry, not repeatedly dropped, etc.), and maintenance is done every 5 years |
SHELF LIFE | 10 years |
MAINTENANCE | Sent to company shop for maintenance every 5 years |
REPAIR | If PCA malfunctions, it will be sent to the company shop for repair |
SANITATION AND SAFETY | - Disposal plastic head covers - 5-digit clinician code (to be entered on number pad) for dosage changes and to open the electronic lock on the lid - Alert sent to hospital if attempt to change dosage is made |
Company Specifications: Big Booming Business
COMPONENT | PRICE/DESCRIPTION |
ADVERTISING | Advertising costs will include client advertising (for example, in health related professions such as hospitals and nursing homes). Approximately $100,000 will be awarded to this branch of business in order to pursue advertising for the new ORAL PCA. More may be awarded to this business sector when the results arrive from the manufacturing and distribution test trials and analysis of cost-benefits have been taken into account. Advertising strategies include pamphlet mail-outs, client consultations, and product-launch marketing. |
TIME TO MARKET | The FDA must first approve of the safety of the design which could take approximately year. The time for the product to get to the market will be approximately 2-3years after the design has been formalized and confirmed; from this point, it will be sent to manufacturing and distribution companies for product analysis and testing. Manufacturing should take six months to come out with a fully functioning version, while trial tests should last about a year. The remaining time should be devoted to analysis of the test trials and perfecting the few prototypes. Distribution should take another six months. |
COMPETITION | The competition for ORAL PCAs will include competition from regular PCA (intravenous) companies such as Smiths Medical. Once the product has been out in the market, we will anticipate other versions of the ORAL PCA to be on the market. We foresee similar companies like Smiths Medical to take on ORAL PCA manufacturing and distribution as popularity for the product grows. |
BUSINESS STRATEGY | The business strategy for the ORAL PCA will be to target health related professional environments. Prior to the launch and after the product has been cleared for safety features (optimally during the closing of our trial runs that have positive results), we expect to participate in various symposiums and forums in the medical field to promote the product. We hope to attract clients from both hospital settings to more privatized sectors of the health field (nursing homes, private practices etc.) Then we hope to contact interested clients. This will include specific client consultations in order to promote and sell the ORAL PCA. These strategies are included in the advertising costs under product-launch marketing and client consultation. |
PRICING | The pricing of the entire ORAL PCA is dependent of the oral medical in the device. The device itself should cost approximately $1000-$2000 dollars each. This does not, however, include accessories and other products or services associated with the device. Accessories and other products will not come out to market until about a year after the device has been fully launched and is successful; this is also dependent on the consumer demand. |
MANUFACTURING | The manufacturing costs will include putting the design through a company that will manufacture prototypes and the actual product once it’s ready for the market. Manufacturing costs should be around $500-$750 per ORAL PCA product. Like other medical innovations, government subsidies or grants may help the initial start-up of the project; if this is the case, manufacturing costs may be lower. |
DISTRIBUTION | Distribution is tied with the manufacturing company and dependent on that timeline. We hope to distribute these products directly to health care providers as well as clinicians in professional health related fields. The distribution of the product will include a formal verbal and hands-on break-down of how the ORAL PCA works and how to prompt patients on its use. For larger hospital settings, we hope to teach the clinicians and administrators how to use the product during a post-consultation session before distributing this to other patients. This will be included in any fees directed in the distribution costs. These costs should run about $500 dollars per session; it is not optional. Shipping and handling will be directed through the company and this will be an extra $100. |
SALES | Around twice the annual sales of other competitors |
REPAIR & UPGRADES | Can be sent back in for repair within two years time for free, upgrades include larger versions that can store greater amounts of medication at time |
FINANCIAL | Requires investments of $200,000 at least. |
REGULATIONS | The product can be distributed to hospitals only. |
POLLUTION | It saves a lot of energy that would be expended to other actions. This product saves both time and effort for the patient and the administrators. However, the disposable tips are not that environmentally friendly. |
INTELLECTUAL PROPERTY | It is its own line of product, the next closest is Avancen MOD but that is designed for bedside administration only. Therefore, there are exclusive rights to this patent. |
PRODUCT LIABILITY | Product liability involves potential problems with manufacturing defects, design defects, and failure to warn of potential failures. This could involve unhygienic mouthpieces, tubes, etc. |